These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25301722)

  • 1. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
    Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
    Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer.
    Kim SJ; Noh TH; Son S; Kim DH; Kim W; Lee Y; Choo J; Heo G; Kim MJ; Chung HY; Jung Y; Jung JH; Moon HR; Im E
    Cell Death Dis; 2018 Aug; 9(9):877. PubMed ID: 30158525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells.
    Feng YH; Tsao CJ; Wu CL; Chang JG; Lu PJ; Yeh KT; Shieh GS; Shiau AL; Lee JC
    Cancer Sci; 2010 Sep; 101(9):2033-8. PubMed ID: 20624167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
    Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
    J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan.
    Braun AH; Stark K; Dirsch O; Hilger RA; Seeber S; Vanhoefer U
    Anticancer Drugs; 2005 Nov; 16(10):1099-108. PubMed ID: 16222152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
    Mueller KL; Hunter LA; Ethier SP; Boerner JL
    Cancer Res; 2008 May; 68(9):3314-22. PubMed ID: 18451158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
    Hong SY; Shih YP; Li T; Carraway KL; Lo SH
    Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.
    Yao Z; Darowski K; St-Denis N; Wong V; Offensperger F; Villedieu A; Amin S; Malty R; Aoki H; Guo H; Xu Y; Iorio C; Kotlyar M; Emili A; Jurisica I; Neel BG; Babu M; Gingras AC; Stagljar I
    Mol Cell; 2017 Jan; 65(2):347-360. PubMed ID: 28065597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface epidermal growth factor receptors increase Src and c-Cbl activity and receptor ubiquitylation.
    Parks EE; Ceresa BP
    J Biol Chem; 2014 Sep; 289(37):25537-45. PubMed ID: 25074934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.
    Müller KM; Tveteraas IH; Aasrum M; Ødegård J; Dawood M; Dajani O; Christoffersen T; Sandnes DL
    BMC Cancer; 2011 Oct; 11():421. PubMed ID: 21961726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
    Thelemann A; Petti F; Griffin G; Iwata K; Hunt T; Settinari T; Fenyo D; Gibson N; Haley JD
    Mol Cell Proteomics; 2005 Apr; 4(4):356-76. PubMed ID: 15657067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
    Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
    Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells.
    Song N; Liu S; Zhang J; Liu J; Xu L; Liu Y; Qu X
    Int J Mol Sci; 2014 Apr; 15(4):5838-51. PubMed ID: 24714091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.
    Irwin ME; Bohin N; Boerner JL
    Cancer Biol Ther; 2011 Oct; 12(8):718-26. PubMed ID: 21775822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation.
    Soltoff SP
    J Biol Chem; 1998 Sep; 273(36):23110-7. PubMed ID: 9722539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
    Phuchareon J; McCormick F; Eisele DW; Tetsu O
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
    Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
    J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
    Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet irradiation can induce evasion of colon cancer cells from stimulation of epidermal growth factor.
    Adachi S; Yasuda I; Nakashima M; Yamauchi T; Kawaguchi J; Shimizu M; Itani M; Nakamura M; Nishii Y; Yoshioka T; Hirose Y; Okano Y; Moriwaki H; Kozawa O
    J Biol Chem; 2011 Jul; 286(29):26178-87. PubMed ID: 21646361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.